FDA DEVICE FACTS
Liver fat ultrasound quantitative system, The FattaLab (FL-CC M1, FL-CC M1_Pro)
Eieling Technology (Shenzhen) Limited
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The FattaLab provides B-mode imaging and is intended to measure ultrasound attenuation coefficient (MAP: Mobile Attenuation Parameter) of liver tissue for adult patients at 3.5MHz. The MAP may be used as an aid to diagnosis and monitoring of adult patients with liver disease, as part of an overall assessment of the liver. This device is intended for use by qualified and appropriately trained healthcare professionals in hospitals, clinics or any facility where healthcare is provided to measure the ultrasound attenuation coefficient of the liver in patients with liver disease. It does so in a painless and completely non-invasive manner. To ensure safe and effective operation, the operator shall meet the following requirements:
1) Receive training as required by local, state and national regulations, if applicable
2) Receive additional training as required by the authorized distributor or EIELING
3) Has a thorough knowledge and understanding of the material presented in the labeling
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。